Get the Stockscreener App
1.29
2.42%
0.05
Hcw Biologics Inc stock is traded at $1.29, with a volume of 28,811.
It is up +2.42% in the last 24 hours and down -10.56% over the past month.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
See More
Previous Close:
$1.24
Open:
$1.28
24h Volume:
28,811
Relative Volume:
0.35
Market Cap:
$4.17M
Revenue:
$832.80K
Net Income/Loss:
$-21.55M
P/E Ratio:
-0.1071
EPS:
-12.0465
Net Cash Flow:
$-12.71M
1W Performance:
-5.93%
1M Performance:
-10.56%
6M Performance:
-70.19%
1Y Performance:
-90.38%
1-Day Range:
$1.25
$1.32
1-Week Range:
$1.19
$1.65
52-Week Range:
$0.9532
$41.20
Hcw Biologics Inc Stock (HCWB) Company Profile
Name
Hcw Biologics Inc
Sector
Industry
Phone
954-842-2024
Address
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
1.27 | 4.07M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.46 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.11 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.87 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.40 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Hcw Biologics Inc Stock (HCWB) Latest News
Market Leaders: Can HCW Biologics Inc. stock double in the next yearJuly 2025 PreEarnings & Low Volatility Stock Suggestions - baoquankhu1.vn
RSI Check: What is the earnings history of HCW Biologics IncJuly 2025 Earnings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Risk Off: Can HCW Biologics Inc stock double in the next yearPortfolio Value Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
HCW Biologics restructures obligations to regain Nasdaq compliance - MSN
US Stocks Recap: Is HCW Biologics Inc. forming a breakout patternJuly 2025 Highlights & Verified Momentum Watchlists - baoquankhu1.vn
Is HCW Biologics Inc. stock recession proofEarnings Recap Summary & Weekly Sector Rotation Insights - Улправда
How analysts rate HCW Biologics Inc. stock todayQuarterly Trade Summary & AI Enhanced Execution Alerts - ulpravda.ru
Will HCW Biologics Inc. stock attract ESG investorsJuly 2025 Spike Watch & Safe Capital Preservation Plans - Улправда
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions - Investing.com Nigeria
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions By Investing.com - Investing.com South Africa
HCW Biologics Restructures Obligations to Regain Nasdaq Compliance - TipRanks
HCW Biologics Achieves Nasdaq Compliance Milestone - TradingView — Track All Markets
Returns Recap: Will HCW Biologics Inc stock attract ESG investorsEarnings Beat & Daily Price Action Insights - moha.gov.vn
HCW Biologics Granted Nasdaq Compliance Extension - MSN
Aug Analyst Calls: Is HCW Biologics Inc stock recession proofGDP Growth & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
US Market Recap: How analysts rate HCW Biologics Inc stock todayWeekly Investment Summary & Precise Buy Zone Identification - Bộ Nội Vụ
HCW Biologics (NASDAQ:HCWB) Shares Down 0.2% – Time to Sell? - Defense World
Reviewing HCW Biologics (NASDAQ:HCWB) and ImmunityBio (NASDAQ:IBRX) - Defense World
HCW Biologics Earnings Notes - Trefis
Is HCW Biologics Inc. stock gaining market shareJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Is HCW Biologics Inc. stock attractive for growth ETFsMarket Performance Report & Low Drawdown Investment Ideas - Улправда
Is HCW Biologics Inc. stock a buy in volatile markets2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
Can HCW Biologics Inc. stock deliver consistent earnings growthMarket Activity Summary & AI Forecasted Entry/Exit Points - DonanımHaber
Can HCW Biologics Inc. stock deliver strong Q4 earningsMarket Activity Report & Community Trade Idea Sharing - bolumsonucanavari.com
HCW Biologics Inc Stock Analysis and ForecastREITs Market Trends & Investment Timing Techniques - earlytimes.in
Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Is HCW Biologics Inc. overvalued or undervalued? - Markets Mojo
HCW Biologics Amends License Agreement with Trimmune - MSN
How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser
HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World
HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - moha.gov.vn
Form 8-KCurrent report - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN
HCW Biologics Inc. (HCWB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HCW Biologics Secures $4M Through Warrant Exercise - MSN
Why HCW Biologics Inc. stock attracts high net worth investorsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Is HCW Biologics Inc. stock positioned well for digital economyMarket Movers & Safe Entry Trade Reports - newser.com
Will HCW Biologics Inc. stock benefit from infrastructure spending2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
HCW Biologics Begins Phase 1 Trial for HCW9302 - MSN
[8-K] HCW Biologics Inc. Reports Material Event | HCWB SEC FilingForm 8-K - Stock Titan
Insiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value - simplywall.st
What analysts say about HCW Biologics Inc stockSector Rotation Strategies & Low Risk Trading Growth - earlytimes.in
Why retail investors favor HCW Biologics Inc. stockShort Setup & Daily Oversold Stock Bounce Ideas - newser.com
HCW Biologics secures $4 million through warrant exercise agreement By Investing.com - Investing.com Nigeria
Hcw Biologics Inc Stock (HCWB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):